Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,166 | -103,747 | -63,039 | -30,325 | -87,703 |
| Depreciation Amortization | 5,160 | 3,703 | 2,260 | 1,051 | 4,104 |
| Accounts receivable | -341 | -1,052 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,637 | 7,433 | 1,966 | -1,279 | N/A |
| Other Working Capital | 2,861 | 10,761 | 7,123 | 336 | 4,937 |
| Other Operating Activity | 6,853 | -47 | 2,095 | 3,378 | 3,824 |
| Operating Cash Flow | $-121,996 | $-82,949 | $-49,595 | $-26,839 | $-74,838 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -132,991 | -46,708 | -45,235 | 3,500 | N/A |
| PPE Investments | -5,259 | -4,030 | -2,992 | -1,193 | -5,177 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 23,771 |
| Investing Cash Flow | $-138,250 | $-50,738 | $-48,227 | $2,307 | $18,594 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 212,519 | 1,298 | 799 | 116 | N/A |
| Other Financing Activity | 106,145 | 105,874 | 97,935 | 0 | 67,014 |
| Financing Cash Flow | $318,664 | $107,172 | $98,734 | $116 | $67,014 |
| Beginning Cash Position | 89,232 | 89,232 | 89,232 | 89,232 | 78,462 |
| End Cash Position | 147,650 | 62,717 | 90,144 | 64,816 | 89,232 |
| Net Cash Flow | $58,418 | $-26,515 | $912 | $-24,416 | $10,770 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,996 | -82,949 | -49,595 | -26,839 | -74,838 |
| Capital Expenditure | -5,259 | -4,030 | -2,992 | -1,193 | N/A |
| Free Cash Flow | -127,255 | -86,979 | -52,587 | -28,032 | -74,838 |